Koorosh Shahpasand

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Spinal Cord Injury

Cerebrospinal Fluid

Mild Cognitive Impairment

Top Venues

Molecular neurobiology

Cellular and molecular neurobiology

Therapeutic delivery

Journal of neurochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Mahsa Pourhamzeh, Mohammad Taghi Joghataei, Soraya Mehrabi, Reza Ahadi, Seyed Mohammad Massood Hojjati, Nasrin Fazli, Seyed Massood Nabavi, Hossein Pakdaman, Koorosh Shahpasand
Retraction Note: The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic. Cellular and molecular neurobiology 44 (1) (2024)
Nasrin Seddigh, Delaram Taabodi, Maedeh Dadzadi, Koorosh Shahpasand
cis P-tau Accumulation Triggers Neurodegeneration after Ischemic Stroke. ACS omega 9 (5) (2024)
Aisan Farhadi, Mehdi Totonchi, Seyed Masood Nabavi, Hossein Baharvand, Hossein Pakdaman, Ensiyeh Hajizadeh-Saffar, Seyed Ahmad Mousavi, Fatemeh Hadi, Hamed Al-Sinawi, Quan Li, Jin-San Zhang, Yaser Tahamtani, Koorosh Shahpasand
P38 initiates degeneration of midbrain GABAergic and glutamatergic neurons in diabetes models. The European journal of neuroscience 56 (1) (2022)
Shaqayeq Roqanian, Shahin Ahmadian, Seyed Masood Nabavi, Hossein Pakdaman, Mahshid Shafiezadeh, Ghazaleh Goudarzi, Koorosh Shahpasand
Tau nuclear translocation is a leading step in tau pathology process through P53 stabilization and nucleolar dispersion. Journal of neuroscience research 100 (4) (2022)
Elnaz Nakhjiri, Shaqayeq Roqanian, Hamid Soltani Zangbar, Manouchehr Seyedi Vafaee, Daryoush Mohammadnejad, Shahin Ahmadian, Selva Zamanzadeh, Ehsan Ehsani, Parviz Shahabi, Koorosh Shahpasand
Spinal Cord Injury Causes Prominent Tau Pathology Associated with Brain Post-Injury Sequela. Molecular neurobiology 59 (7) (2022)
Fatemeh Hadi, Hassan Akrami, Mehdi Totonchi, Abdolrazagh Barzegar, Seyed Massood Nabavi, Koorosh Shahpasand
α-synuclein abnormalities trigger focal tau pathology, spreading to various brain areas in Parkinson disease. Journal of neurochemistry 157 (3) (2021)
Mahsa Pourhamzeh, Mohammad Taghi Joghataei, Soraya Mehrabi, Reza Ahadi, Seyed Mohammad Massood Hojjati, Nasrin Fazli, Seyed Massood Nabavi, Hossein Pakdaman, Koorosh Shahpasand
The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic. Cellular and molecular neurobiology 41 (6) (2020)
Elnaz Nakhjiri, Manuchehr S Vafaee, Seyed Mohammad Massod Hojjati, Parviz Shahabi, Koorosh Shahpasand
Tau Pathology Triggered by Spinal Cord Injury Can Play a Critical Role in the Neurotrauma Development. Molecular neurobiology 57 (11) (2020)
Niloofar Arsalan, Elahe Hassan Kashi, Anwarul Hasan, Mona Edalat Doost, Behnam Rasti, Bilal Ahamad Paray, Mona Zahed Nakhjiri, Soyar Sari, Majid Sharifi, Koorosh Shahpasand, Keivan Akhtari, Setareh Haghighat, Mojtaba Falahati
Exploring the Interaction of Cobalt Oxide Nanoparticles with Albumin, Leukemia Cancer Cells and Pathogenic Bacteria by Multispectroscopic, Docking, Cellular and Antibacterial Approaches. International journal of nanomedicine 15 (2020)
Fatemeh Jahansooz, Bahman Ebrahimi Hosseinzade, Ashrafalsadat Hatamian Zarmi, Fatemeh Hadi, Seyed Mohammad Massood Hojjati, Koorosh Shahpasand
Dopamine-loaded poly (butyl cyanoacrylate) nanoparticles reverse behavioral deficits in Parkinson's animal models. Therapeutic delivery 11 (6) (2020)
Roghayeh Naserkhaki, Selva Zamanzadeh, Hossein Baharvand, Seyed Massood Nabavi, Hossein Pakdaman, Sahba Shahbazi, Massood Vosough, Gholam Ghaedi, Abdolrazzagh Barzegar, Davood Mirtorabi, Mohamad Hedayatshodeh, Ehsan Ehsani, Mojtaba Falahati, Mohammad Javad Hajipour, Koorosh Shahpasand
cis pT231-Tau Drives Neurodegeneration in Bipolar Disorder. ACS chemical neuroscience 10 (3) (2019)
Masoume Alipour, Seyed Massood Nabavi, Leila Arab, Massoud Vosough, Hossein Pakdaman, Ehsan Ehsani, Koorosh Shahpasand
Stem cell therapy in Alzheimer's disease: possible benefits and limiting drawbacks. Molecular biology reports 46 (1) (2018)